Showing results (11-20 of 222) with videos related to
Sort By:
Pageof 23
Wiener Medizinische Wochenschrift (1946)|August 18, 2010
Villa Metabolica - a center of excellence for the diagnosis and treatment of lysosomal storage disordersMichael BeckDevelopmental Medicine and Child Neurology|November 2, 2017
Treatment strategies for lysosomal storage disordersMichael BeckExpert Opinion on Investigational Drugs|May 31, 2002
Agalsidase alfa--a preparation for enzyme replacement therapy in Anderson-Fabry diseaseMichael BeckExpert Opinion on Biological Therapy|February 25, 2009
Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safetyMichael BeckTherapeutics and Clinical Risk Management|October 10, 2009
Alglucosidase alfa: Long term use in the treatment of patients with Pompe diseaseMichael BeckExpert Opinion on Emerging Drugs|June 19, 2010
Emerging drugs for lysosomal storage diseasesMichael BeckDermatology (Basel, Switzerland)|May 31, 2002
Factor VII deficiency and a copper metabolism disorder in a patient with Klippel-Trenaunay syndromeNicolas J Mueller, Peter Schiller, Norikazu Shimizu, et al.Lymphatic Research and Biology|December 31, 2004
Severe lymphatic microangiopathy in Fabry diseaseBeatrice R Amann-Vesti, Gabriele Gitzelmann, Urs Widmer, et al.Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 11, 2007
Altered myocardial motion pattern in Fabry patients assessed with CMR-taggingAndrea K Rutz, Christoph F Juli, Salome Ryf, et al.European Journal of Pediatrics|February 27, 2009
Fabry disease in children and the effects of enzyme replacement treatmentGuillem Pintos-Morell, Michael BeckPageof 23